A61K 39/005
Trypanosoma antigens
A61K39/005 (Trypanosoma antigens) appears on 45 US grants and 69 published applications in this corpus.
Search patents in A61K- Granted patents
- 45
- Published applications
- 69
- Assignees
- 55
- Inventors
- 144
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 4 |
| 2009 | 0 | 2 |
| 2010 | 2 | 6 |
| 2011 | 2 | 3 |
| 2012 | 1 | 1 |
| 2013 | 0 | 3 |
| 2014 | 3 | 2 |
| 2015 | 4 | 3 |
| 2016 | 2 | 0 |
| 2017 | 3 | 8 |
| 2018 | 3 | 2 |
| 2019 | 3 | 4 |
| 2020 | 3 | 3 |
| 2021 | 3 | 4 |
| 2022 | 1 | 3 |
| 2023 | 1 | 5 |
| 2024 | 3 | 6 |
| 2025 | 1 | 2 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Chagas disease vaccine antigens with improved stability and decreased aggregation29 Sep 2026US 12,746,280 B2Baylor College of Medicine
- Anti-parasitic immunological compositions9 Jun 2026US 12,648,993 B2Board of Regents of the University of Nebraska
- Serum free intracellular pathogen vaccine3 Mar 2026US 12,564,626 B2Intervet Inc.
- Use of trimanganese tetraoxide particles in preparation of vaccine adjuvant11 Nov 2025US 12,465,634 B2Guangzhou Realbenefitspot Pharmaceutical Co., Ltd.
- Trypanosomal vaccine31 Dec 2024US 12,178,864 B2Genome Research Limited
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Serum free intracellular pathogen vaccine11 Jun 2026US 2026/0158132 A1Intervet Inc.
- Use of trimanganese tetraoxide particles in preparation of vaccine adjuvant20 Feb 2025US 2025/0057947 A1Guangzhou Realbenefitspot Pharmaceutical Co., Ltd.
- Recombinant baculoviruses, vaccine compositions that comprise it, and methods for inducing an immune response2 Jan 2025US 2025/0000961 A1Instituto Nacional De Tecnologia Agropecuaria
- Recombinant chimeric protein, use thereof, and composition14 Nov 2024US 2024/0376161 A1
Most cited
By later US patents
- Immuno-potentiating systems for preparation of immunogenic materials21US 5,726,292 A1998
- Diagnostic assay for Trypanosoma cruzi infection18US 7,888,135 B2University of Georgia Research Foundation, Inc. · 2011
- Malaria treatments12US 5,726,166 ABritish Technology Group Limited · 1998
- Mixed allergen compositions and methods for using the same11US 10,143,742 B2The Board of Trustees of the Leland Stanford Junior University · 2018
- Prophylactic and therapeutic immunization against protozoan infection and disease11US 6,875,584 B1University of Georgia Research Foundation, Inc. · 2005